Publicaciones en colaboración con investigadores/as de Hospital Universitario Nuestra Señora de Candelaria (3)

2022

  1. Clinical Factors Associated With Long-Term Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib: Real-World AXILONG Study

    Clinical Genitourinary Cancer, Vol. 20, Núm. 1, pp. 25-34

2018

  1. Pazopanib: Evidence review and clinical practice in the management of advanced renal cell carcinoma

    BMC Pharmacology and Toxicology, Vol. 19, Núm. 1

2013

  1. Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study

    British Journal of Cancer, Vol. 108, Núm. 12, pp. 2565-2572